US8294975B2
(en)
|
1997-08-25 |
2012-10-23 |
Donnelly Corporation |
Automotive rearview mirror assembly
|
PT1061900E
(en)
*
|
1999-01-14 |
2005-04-29 |
Noven Pharma |
COMPOSITIONS AND METHODS FOR LIBERATION OF A DRUG
|
US20020004065A1
(en)
|
2000-01-20 |
2002-01-10 |
David Kanios |
Compositions and methods to effect the release profile in the transdermal administration of active agents
|
WO2007053710A2
(en)
*
|
2005-11-01 |
2007-05-10 |
Donnelly Corporation |
Interior rearview mirror with display
|
DE10025971B4
(en)
*
|
2000-05-25 |
2004-09-02 |
Lts Lohmann Therapie-Systeme Ag |
Transdermal therapeutic system in plaster form with reduced tendency for drug crystallization and its use
|
USRE44145E1
(en)
|
2000-07-07 |
2013-04-09 |
A.V. Topchiev Institute Of Petrochemical Synthesis |
Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties
|
US6756379B2
(en)
*
|
2001-07-26 |
2004-06-29 |
Taro Pharmaceutical Industries Ltd. |
Non-sedating barbiturate compounds as neuroprotective agents
|
US7683071B2
(en)
*
|
2000-07-26 |
2010-03-23 |
Taro Pharmaceuticals Industries Ltd. |
Composition and method for improved bioavailability and enhanced brain delivery of 5,5-diphenyl barbituric acid
|
US6939873B2
(en)
*
|
2000-07-26 |
2005-09-06 |
Taro Pharmaceuticals Industries Limited |
Non-sedating barbituric acid derivatives
|
US20040092494A9
(en)
*
|
2000-08-30 |
2004-05-13 |
Dudley Robert E. |
Method of increasing testosterone and related steroid concentrations in women
|
US20040002482A1
(en)
*
|
2000-08-30 |
2004-01-01 |
Dudley Robert E. |
Androgen pharmaceutical composition and method for treating depression
|
HUP0303719A2
(en)
*
|
2000-10-16 |
2004-03-01 |
Neopharm, Inc. |
Liposomal pharmaceutical composition of mitoxantrone and process for their preparation
|
US6479076B2
(en)
*
|
2001-01-12 |
2002-11-12 |
Izhak Blank |
Nicotine delivery compositions
|
US20050113510A1
(en)
|
2001-05-01 |
2005-05-26 |
Feldstein Mikhail M. |
Method of preparing polymeric adhesive compositions utilizing the mechanism of interaction between the polymer components
|
US20050215727A1
(en)
|
2001-05-01 |
2005-09-29 |
Corium |
Water-absorbent adhesive compositions and associated methods of manufacture and use
|
ATE438418T1
(en)
|
2001-05-01 |
2009-08-15 |
Av Topchiev Inst Petrochemical |
HYDROGEL COMPOSITIONS
|
US6803420B2
(en)
|
2001-05-01 |
2004-10-12 |
Corium International |
Two-phase, water-absorbent bioadhesive composition
|
US8541021B2
(en)
|
2001-05-01 |
2013-09-24 |
A.V. Topchiev Institute Of Petrochemical Synthesis |
Hydrogel compositions demonstrating phase separation on contact with aqueous media
|
US8840918B2
(en)
|
2001-05-01 |
2014-09-23 |
A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences |
Hydrogel compositions for tooth whitening
|
US8206738B2
(en)
|
2001-05-01 |
2012-06-26 |
Corium International, Inc. |
Hydrogel compositions with an erodible backing member
|
JP4865958B2
(en)
*
|
2001-05-23 |
2012-02-01 |
株式会社トクホン |
Analgesic anti-inflammatory patch with local action
|
EP1406633B1
(en)
*
|
2001-06-18 |
2011-10-05 |
Noven Pharmaceuticals, Inc. |
Enhanced drug delivery in transdermal systems
|
PL211339B1
(en)
*
|
2001-07-09 |
2012-05-31 |
Zonagen |
Methods and materials for the treatment of testosterone deficiency in men
|
US7737185B2
(en)
*
|
2001-07-09 |
2010-06-15 |
Repros Therapeutics Inc. |
Methods and compositions with trans-clomiphene
|
US6805878B2
(en)
*
|
2001-09-13 |
2004-10-19 |
Noven Pharmaceuticals, Inc. |
Transdermal administration of ACE inhibitors
|
US20070053976A1
(en)
*
|
2002-05-17 |
2007-03-08 |
Eisai R & D Management Co., Ltd. |
Novel combination of drugs as antidepressant
|
AU2003298514A1
(en)
*
|
2002-05-17 |
2004-05-04 |
Eisai Co., Ltd. |
Methods and compositions using cholinesterase inhibitors
|
WO2003105099A1
(en)
|
2002-06-06 |
2003-12-18 |
Donnelly Corporation |
Interior rearview mirror system with compass
|
US8039452B2
(en)
*
|
2002-06-18 |
2011-10-18 |
Pola Pharma Inc. |
Antifungal medicinal compositions
|
US8246979B2
(en)
|
2002-07-30 |
2012-08-21 |
Ucb Pharma Gmbh |
Transdermal delivery system for the administration of rotigotine
|
US8246980B2
(en)
*
|
2002-07-30 |
2012-08-21 |
Ucb Pharma Gmbh |
Transdermal delivery system
|
AU2003278863A1
(en)
|
2002-09-20 |
2004-04-08 |
Donnelly Corporation |
Mirror reflective element assembly
|
US8758804B2
(en)
*
|
2002-11-05 |
2014-06-24 |
Fadim S.R.L. |
Controlled and continued delivery of rifaximin and/or other substances
|
EP1569627B1
(en)
*
|
2002-12-11 |
2008-11-12 |
Taro Pharmaceutical Industries Ltd. |
Method of treating movement disorders using barbituric acid derivatives
|
ATE463246T1
(en)
*
|
2003-01-23 |
2010-04-15 |
Shire Holdings Ag |
FORMULATION AND METHOD FOR TREATING THROMBOCYTHEMIA
|
US20040161395A1
(en)
*
|
2003-02-14 |
2004-08-19 |
Patil Anjali Abhimanyu |
Cosmetic compositions containing composite siloxane polymers
|
ATE333271T1
(en)
*
|
2003-02-21 |
2006-08-15 |
Schering Ag |
UV-STABLE TRANSDERMAL PLASTER
|
WO2004075933A2
(en)
*
|
2003-02-26 |
2004-09-10 |
Lavipharm S.A. |
Devices for releasing volatile substances and methods of producing the devices
|
DE602004009414T2
(en)
*
|
2003-03-14 |
2008-07-24 |
Agi Therapeutics Research Ltd. |
TREATMENT OF GASTROINTESTINAL DISEASES WITH N-2,3,3-TETRAMETHYLBICYCLO- [2.2.1] HEPTAN-2-AMINE
|
US20070224284A1
(en)
*
|
2004-03-12 |
2007-09-27 |
John Devane |
Methods and compositions comprising at least one alpha3 beta4 nAChR antagonist or pharmaceutically acceptable salt thereof
|
DE10315878B4
(en)
*
|
2003-04-08 |
2009-06-04 |
Schwarz Pharma Ag |
Device for transdermal administration of fesoterodine and use
|
KR101015546B1
(en)
|
2003-08-26 |
2011-02-16 |
조선대학교산학협력단 |
Patch preparation for nail
|
US20050187278A1
(en)
*
|
2003-08-28 |
2005-08-25 |
Pharmacia Corporation |
Treatment or prevention of vascular disorders with Cox-2 inhibitors in combination with cyclic AMP-specific phosphodiesterase inhibitors
|
CA2544291C
(en)
*
|
2003-10-27 |
2013-01-08 |
University Of Basel |
Transdermal drug delivery method and system
|
MXPA06003769A
(en)
*
|
2003-11-04 |
2006-07-03 |
Shire Lab Inc |
Sustained release of positively charged pharmacologically active molecules from a matrix containing polymers with polarized oxygen atoms.
|
WO2005046663A1
(en)
|
2003-11-04 |
2005-05-26 |
Shire Laboratories, Inc. |
Compositions of quaternary ammonium containing bioavailability enhancers
|
JP5610663B2
(en)
|
2003-11-04 |
2014-10-22 |
スパーナス ファーマシューティカルズ インコーポレイテッド |
Trospium once a day dosage form
|
US8668925B2
(en)
*
|
2003-12-12 |
2014-03-11 |
Bayer Intellectual Property Gmbh |
Transdermal delivery of hormones without the need of penetration enhancers
|
DE10360592A1
(en)
*
|
2003-12-19 |
2005-07-28 |
Beiersdorf Ag |
Plaster system for the administration of antihistamines
|
DE10361306A1
(en)
*
|
2003-12-24 |
2005-07-28 |
Lts Lohmann Therapie-Systeme Ag |
Wound dressing and wound dressing with a vasoconstrictive ingredient, and manufacturing method therefor
|
WO2005074894A1
(en)
|
2004-01-30 |
2005-08-18 |
Corium International |
Rapidly dissolving film for delivery of an active agent
|
US20050271597A1
(en)
*
|
2004-02-13 |
2005-12-08 |
Keith Alec D |
Prostate hypertrophy treatment composition and method
|
US20070190125A1
(en)
|
2004-03-03 |
2007-08-16 |
Constantine Georgiades |
Positioning feature for aiding use of film or strip product
|
US20050237440A1
(en)
*
|
2004-03-16 |
2005-10-27 |
Vision-Ease Lens |
Method and device to enhance the readability of a liquid crystal display through polarized lenses
|
EP1743621B1
(en)
|
2004-04-28 |
2014-03-05 |
Cosmo Oil Co., Ltd. |
Hair restorer
|
NZ550963A
(en)
*
|
2004-04-29 |
2008-11-28 |
Caldwell Galer Inc |
Topical methadone compositions and methods for using the same
|
US8173155B2
(en)
*
|
2004-06-01 |
2012-05-08 |
Hisamitsu Pharmaceutical Co., Inc. |
Adhesive patch
|
WO2006003651A2
(en)
*
|
2004-07-02 |
2006-01-12 |
Taro Pharmaceutical Industries, Ltd |
A process for preparing 1-methoxymethyl-5,5-diphenylbarbituric acid
|
BRPI0513129A
(en)
*
|
2004-07-14 |
2008-04-29 |
Repros Therapeutics Inc |
Method of treating a condition selected from the group consisting of benign prostate hypertrophy, prostate cancer, elevated triglycerides, high cholesterol, and hypogonadism.
|
US7700608B2
(en)
*
|
2004-08-04 |
2010-04-20 |
Shire Holdings Ag |
Quinazoline derivatives and their use in the treatment of thrombocythemia
|
US20060030574A1
(en)
*
|
2004-08-04 |
2006-02-09 |
Shire Holdings Ag |
Quinazoline derivatives useful for the treatment of peripheral arterial disease and as phosphodiesterase inhibitors
|
CN103497713B
(en)
|
2004-08-05 |
2018-07-17 |
考里安国际公司 |
Adhesive composition
|
JP4745747B2
(en)
*
|
2004-08-12 |
2011-08-10 |
日東電工株式会社 |
Fentanyl-containing patch preparation
|
JP4824963B2
(en)
*
|
2004-08-12 |
2011-11-30 |
日東電工株式会社 |
Patch and patch preparation
|
EP1802258A4
(en)
|
2004-09-13 |
2015-09-23 |
Chrono Therapeutics Inc |
Biosynchronous transdermal drug delivery
|
US8252321B2
(en)
|
2004-09-13 |
2012-08-28 |
Chrono Therapeutics, Inc. |
Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
|
WO2006036899A2
(en)
*
|
2004-09-27 |
2006-04-06 |
Corium International, Inc. |
Transdermal systems for the delivery of estrogens and progestins
|
WO2006041911A2
(en)
|
2004-10-08 |
2006-04-20 |
Noven Pharmaceuticals, Inc. |
Device transdermal administration of drugs including acrylic polymers
|
SI1814531T1
(en)
|
2004-10-21 |
2010-10-29 |
Durect Corp |
Transdermal delivery systems
|
US8252319B2
(en)
|
2004-10-21 |
2012-08-28 |
Durect Corporation |
Transdermal delivery system for sufentanil
|
US7766658B2
(en)
*
|
2004-11-30 |
2010-08-03 |
Align Technology, Inc. |
Systems and methods for intra-oral diagnosis
|
US20060115785A1
(en)
*
|
2004-11-30 |
2006-06-01 |
Chunhua Li |
Systems and methods for intra-oral drug delivery
|
US20060115782A1
(en)
*
|
2004-11-30 |
2006-06-01 |
Chunhua Li |
Systems and methods for coating a dental appliance
|
US7947508B2
(en)
*
|
2004-11-30 |
2011-05-24 |
Align Technology, Inc. |
Systems and methods for intra-oral diagnosis
|
US8080560B2
(en)
|
2004-12-17 |
2011-12-20 |
3M Innovative Properties Company |
Immune response modifier formulations containing oleic acid and methods
|
JP4704764B2
(en)
*
|
2005-02-03 |
2011-06-22 |
日東電工株式会社 |
Nail adhesive composition and nail patch
|
PL219509B1
(en)
*
|
2005-02-04 |
2015-05-29 |
Repros Therapeutics Inc |
Methods and materials with trans-clomiphen for treatment of sterility of men
|
RU2413508C2
(en)
*
|
2005-03-22 |
2011-03-10 |
Репрос Терапьютикс Инк. |
Trans-clomiphene dosing regimen
|
US20070088012A1
(en)
*
|
2005-04-08 |
2007-04-19 |
Woun Seo |
Method of treating or preventing type-2 diabetes
|
AP2244A
(en)
*
|
2005-04-26 |
2011-06-24 |
Caldwell Galer Inc |
Topical methadone compositions and methods for using the same.
|
US8962013B2
(en)
*
|
2005-05-02 |
2015-02-24 |
Bayer Intellectual Property Gmbh |
Multi-layered transdermal system with triazine UV absorber
|
JP4800778B2
(en)
*
|
2005-05-16 |
2011-10-26 |
日東電工株式会社 |
Dicing pressure-sensitive adhesive sheet and processing method of workpiece using the same
|
ES2527340T3
(en)
|
2005-05-24 |
2015-01-22 |
Chrono Therapeutics, Inc. |
Portable drug delivery device that includes a removable and replaceable dosage or administration element
|
WO2006127905A2
(en)
|
2005-05-24 |
2006-11-30 |
Chrono Therapeutics, Inc. |
Portable drug delivery device
|
KR100764679B1
(en)
*
|
2005-07-22 |
2007-10-09 |
익수제약 주식회사 |
Patches comprising paroxetine for transdermal application
|
TR201815853T4
(en)
|
2005-10-12 |
2018-11-21 |
Besins Healthcare Sarl |
Testosterone gel for use in the treatment of hypogonadism.
|
DE102005050654A1
(en)
*
|
2005-10-20 |
2007-04-26 |
LABTEC Gesellschaft für technologische Forschung und Entwicklung mbH |
lip paving
|
DE102005050431A1
(en)
|
2005-10-21 |
2007-04-26 |
Lts Lohmann Therapie-Systeme Ag |
Transdermal therapeutic system for the administration of lipophilic and / or less skin-permeable active ingredients
|
WO2007109288A2
(en)
*
|
2006-03-20 |
2007-09-27 |
Xytis Inc. |
Enantiomerically pure r-etifoxine, pharmaceutical compositions thereof and methods of their use
|
WO2007109289A1
(en)
*
|
2006-03-20 |
2007-09-27 |
Xytis Inc. |
Enantiomerically pure s-etifoxine, pharmaceutical compositions thereof and methods of their use
|
US8124689B2
(en)
*
|
2006-06-06 |
2012-02-28 |
Dow Corning Corporation |
Silicone acrylate hybride composition and method of making same
|
US8569416B2
(en)
|
2006-06-06 |
2013-10-29 |
Dow Corning Corporation |
Single phase silicone acrylate formulation
|
US8614278B2
(en)
|
2006-06-06 |
2013-12-24 |
Dow Corning Corporation |
Silicone acrylate hybrid composition and method of making same
|
US20090238763A1
(en)
|
2006-07-09 |
2009-09-24 |
Chongxi Yu |
High penetration compositions and uses thereof
|
US20090221703A1
(en)
|
2006-07-09 |
2009-09-03 |
Chongxi Yu |
High penetration composition and uses thereof
|
CN101506143B
(en)
*
|
2006-09-03 |
2013-06-05 |
于崇曦 |
Positively charged water-soluble prodrugs of acetaminophen and related compounds with fast skin penetration rate
|
CN104987296B
(en)
*
|
2006-10-03 |
2018-11-23 |
于崇曦 |
Positively charged water-soluble prodrugs of mustards and related compounds with fast skin penetration rate
|
CN101511774B
(en)
*
|
2006-10-03 |
2015-05-13 |
于崇曦 |
Positively charged water-soluble prodrugs of mustard gas and related compounds with fast skin penetration rate
|
US7731604B2
(en)
*
|
2006-10-31 |
2010-06-08 |
Taylor Made Golf Company, Inc. |
Golf club iron head
|
WO2008056139A2
(en)
*
|
2006-11-08 |
2008-05-15 |
Regen Therapeutics Plc |
Transdermal therapy
|
WO2008066704A2
(en)
*
|
2006-11-14 |
2008-06-05 |
Taro Pharmaceuticals North America, Inc. |
Method of improving bioavailability for non-sedating barbiturates
|
US7910597B2
(en)
*
|
2006-11-28 |
2011-03-22 |
Shire Llc |
Substituted quinazolines
|
US8304420B2
(en)
*
|
2006-11-28 |
2012-11-06 |
Shire Llc |
Substituted quinazolines for reducing platelet count
|
US20080131490A1
(en)
*
|
2006-12-01 |
2008-06-05 |
Akinori Hanatani |
Stabilized donepezil-containing patch preparation
|
RU2435570C2
(en)
*
|
2006-12-01 |
2011-12-10 |
Нитто Денко Корпорейшн |
Composition for transcutaneous absorption
|
WO2008150845A1
(en)
*
|
2007-05-31 |
2008-12-11 |
Vanderbilt University |
Screening for wnt pathway modulators and pyrvinium for the treatment of cance
|
PL2170826T3
(en)
|
2007-06-04 |
2022-09-05 |
Techfields Inc |
Pro-drugs of nsaias with very high skin and membranes penetration rates and their new medicinal uses
|
CN101147739B
(en)
|
2007-07-06 |
2010-12-08 |
北京康倍得医药技术开发有限公司 |
Composition containing rotigotine and its use and transdermal patch containing the composition
|
UA96076C2
(en)
|
2007-10-16 |
2011-09-26 |
Репрос Терапьютикс Инк. |
Use of trans-clomiphene
|
JP5209433B2
(en)
*
|
2007-10-19 |
2013-06-12 |
日東電工株式会社 |
Patch preparation
|
HUP0700828A2
(en)
*
|
2007-12-20 |
2010-01-28 |
Richter Gedeon Nyrt |
Transdermal pharmaceutical compositions containing tolperisone alone and in combination
|
US9314524B2
(en)
*
|
2007-12-31 |
2016-04-19 |
Calla Therapeutics Llc |
Topical formulations of Flucytosine
|
US8580281B2
(en)
*
|
2008-02-27 |
2013-11-12 |
Hisamitsu Pharmaceutical Co., Inc. |
Medicated patch
|
ES2661767T3
(en)
*
|
2008-02-27 |
2018-04-03 |
Hisamitsu Pharmaceutical Co., Inc. |
Adhesive skin patch and packaged product
|
WO2009106831A2
(en)
*
|
2008-02-28 |
2009-09-03 |
Syntropharma Limited |
Pharmaceutical composition
|
CN102046171B
(en)
*
|
2008-05-30 |
2013-06-19 |
日东电工株式会社 |
Transdermal preparation
|
CN102014905B
(en)
*
|
2008-05-30 |
2012-11-14 |
日东电工株式会社 |
Donepezil-containing patch preparation and packaging thereof
|
US20110097393A1
(en)
*
|
2008-06-25 |
2011-04-28 |
US WorldMeade, LLC |
Skin Patches and Sustained-Release Formulations Comprising Lofexidine for Transdermal and Oral Delivery
|
US8231906B2
(en)
*
|
2008-07-10 |
2012-07-31 |
Noven Pharmaceuticals, Inc. |
Transdermal estrogen device and delivery
|
EP2307516B1
(en)
*
|
2008-07-28 |
2012-09-05 |
Dow Corning Corporation |
Composite article
|
RU2497679C2
(en)
|
2008-10-02 |
2013-11-10 |
Милан Инк. |
Method of making multilayer adhesive laminated material
|
BRPI0922263B1
(en)
|
2008-12-04 |
2021-08-31 |
Chongxi Yu |
HIGH PENETRATION COMPOSITION OF A MAIN DRUG AND ITS USES
|
AU2010204986B2
(en)
|
2009-01-14 |
2016-06-02 |
Corium International, Inc. |
Transdermal administration of tamsulosin
|
DE102009008256A1
(en)
*
|
2009-02-10 |
2010-08-12 |
Lts Lohmann Therapie-Systeme Ag |
Prodrugs of the type N-hydroxylated amidines, guanidines and / or aminohydrazones for application via the skin
|
RU2544702C2
(en)
|
2009-04-24 |
2015-03-20 |
Хенкель Корпорейшн |
Glues based on silicon-acryl hybrid polymer
|
US8741267B1
(en)
|
2009-06-26 |
2014-06-03 |
Joseph P. Trovato |
Method for treating periodontal disease
|
US8952038B2
(en)
|
2010-03-26 |
2015-02-10 |
Philip Morris Usa Inc. |
Inhibition of undesired sensory effects by the compound camphor
|
BR112012024356A2
(en)
|
2010-03-26 |
2016-05-24 |
Philip Morris Products Sa |
inhibition of sensory irritation during smoking
|
KR20120137373A
(en)
|
2010-04-30 |
2012-12-20 |
테이코쿠 팔마 유에스에이, 인코포레이티드 |
Propynylaminoindan transdermal compositions
|
DE102010024105A1
(en)
*
|
2010-06-17 |
2011-12-22 |
Grünenthal GmbH |
Transdermal administration of memantine
|
EP2670368A4
(en)
*
|
2011-02-03 |
2015-04-15 |
Pharmedica Ltd |
New oral dissolving films for insulin administration, for treating diabetes
|
JP5906302B2
(en)
|
2011-03-24 |
2016-04-20 |
テイコク ファーマ ユーエスエー インコーポレーテッド |
Transdermal composition comprising an agent layer and an agent conversion layer
|
US8828426B2
(en)
|
2011-06-07 |
2014-09-09 |
Zx Pharma, Llc |
Multiparticulate L-carnitine compositions and related methods
|
CA2841785A1
(en)
|
2011-07-06 |
2013-01-10 |
The Parkinson's Institute |
Compositions and methods for treatment of symptoms in parkinson's disease patients
|
UA113291C2
(en)
|
2011-08-04 |
2017-01-10 |
|
TRANSCLOMYPHENE METABOLITES AND THEIR APPLICATIONS
|
EP2584016A1
(en)
|
2011-10-21 |
2013-04-24 |
Dow Corning Corporation |
Single phase silicone acrylate formulation
|
BR112014010223B8
(en)
*
|
2011-10-28 |
2021-02-23 |
Lumena Pharmaceuticals Llc |
use of a composition comprising bile acid recycling inhibitors and pediatric dosage form
|
CN104023718B
(en)
*
|
2011-10-28 |
2017-04-05 |
鲁美纳医药公司 |
For treating the bile acid recycling inhibitors of high cholemia and cholestatic liver disease
|
WO2013070526A1
(en)
|
2011-11-09 |
2013-05-16 |
Teikoku Pharma Usa, Inc. |
Methods for the treatment of skin neoplasms
|
HUE055562T2
(en)
|
2011-11-23 |
2021-11-29 |
Therapeuticsmd Inc |
Natural combination hormone replacement formulations and therapies
|
US9301920B2
(en)
|
2012-06-18 |
2016-04-05 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
JP2013139554A
(en)
|
2011-11-29 |
2013-07-18 |
Dow Corning Corp |
Silicone acrylate hybrid composition and method of making the same
|
US20130211351A1
(en)
*
|
2012-01-31 |
2013-08-15 |
Gruenenthal Gmbh |
Pharmaceutical patch for transdermal administration of (1r,4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexane-1,1'-pyrano[3,4-b]indol]-4-amine
|
EP4356912A2
(en)
|
2012-05-16 |
2024-04-24 |
Techfields Pharma Co., Ltd. |
High penetration prodrug compositions and pharmaceutical composition thereof for treatment of pulmonary conditions
|
US10806697B2
(en)
|
2012-12-21 |
2020-10-20 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US10806740B2
(en)
|
2012-06-18 |
2020-10-20 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
US20150196640A1
(en)
|
2012-06-18 |
2015-07-16 |
Therapeuticsmd, Inc. |
Progesterone formulations having a desirable pk profile
|
US20130338122A1
(en)
|
2012-06-18 |
2013-12-19 |
Therapeuticsmd, Inc. |
Transdermal hormone replacement therapies
|
MX2015005160A
(en)
|
2012-11-02 |
2015-07-17 |
Repros Therapeutics Inc |
Trans-clomiphene for use in cancer therapy.
|
CN104797245B
(en)
|
2012-11-02 |
2018-05-04 |
帝国制药美国公司 |
Iodopropynylbutylcarbamate indane transdermal composition
|
US11266661B2
(en)
|
2012-12-21 |
2022-03-08 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US11246875B2
(en)
|
2012-12-21 |
2022-02-15 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US9180091B2
(en)
|
2012-12-21 |
2015-11-10 |
Therapeuticsmd, Inc. |
Soluble estradiol capsule for vaginal insertion
|
US10471072B2
(en)
|
2012-12-21 |
2019-11-12 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US10537581B2
(en)
|
2012-12-21 |
2020-01-21 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US10568891B2
(en)
|
2012-12-21 |
2020-02-25 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US9314470B2
(en)
|
2012-12-28 |
2016-04-19 |
Noven Pharmaceuticals, Inc. |
Transdermal drug delivery systems for levonorgestrel and ethinyl estradiol
|
US9505737B2
(en)
|
2013-01-11 |
2016-11-29 |
Corsair Pharma, Inc. |
Treprostinil derivative compounds and methods of using same
|
ES2805367T3
(en)
|
2013-01-11 |
2021-02-11 |
Corsair Pharma Inc |
Treprostinil prodrugs
|
US10105487B2
(en)
|
2013-01-24 |
2018-10-23 |
Chrono Therapeutics Inc. |
Optimized bio-synchronous bioactive agent delivery system
|
JP6151935B2
(en)
*
|
2013-03-11 |
2017-06-21 |
日東電工株式会社 |
Transdermal absorption enhancing composition and patch preparation
|
WO2014159798A1
(en)
*
|
2013-03-13 |
2014-10-02 |
Avery Dennison Corporation |
Improving adhesive properties
|
WO2015054608A1
(en)
*
|
2013-10-11 |
2015-04-16 |
Xep, Inc. |
Energy patch
|
EP3145489A1
(en)
|
2014-05-22 |
2017-03-29 |
TherapeuticsMD, Inc. |
Natural combination hormone replacement formulations and therapies
|
AU2016211330A1
(en)
|
2015-01-28 |
2017-08-03 |
Chrono Therapeutics Inc. |
Drug delivery methods and systems
|
KR102048682B1
(en)
*
|
2015-02-09 |
2019-11-27 |
다우 실리콘즈 코포레이션 |
Multiphase Silicone Acrylic Hybrid Viscoelastic Composition and Method for Making the Same
|
US10679516B2
(en)
|
2015-03-12 |
2020-06-09 |
Morningside Venture Investments Limited |
Craving input and support system
|
US20180235903A1
(en)
*
|
2015-03-13 |
2018-08-23 |
Amneal Pharmaceuticals Llc |
Fentanyl Transdermal Delivery System
|
US9643911B2
(en)
|
2015-06-17 |
2017-05-09 |
Corsair Pharma, Inc. |
Treprostinil derivatives and compositions and uses thereof
|
US9394227B1
(en)
|
2015-06-17 |
2016-07-19 |
Corsair Pharma, Inc. |
Treprostinil derivatives and compositions and uses thereof
|
US10328087B2
(en)
|
2015-07-23 |
2019-06-25 |
Therapeuticsmd, Inc. |
Formulations for solubilizing hormones
|
EP3411023A1
(en)
|
2016-02-05 |
2018-12-12 |
3M Innovative Properties Company |
Transdermal drug delivery systems with fluorosilicone release liners
|
US10286077B2
(en)
|
2016-04-01 |
2019-05-14 |
Therapeuticsmd, Inc. |
Steroid hormone compositions in medium chain oils
|
BR112018070199A2
(en)
|
2016-04-01 |
2019-01-29 |
Therapeuticsmd Inc |
pharmaceutical composition of steroid hormone
|
WO2018002673A1
(en)
|
2016-07-01 |
2018-01-04 |
N4 Pharma Uk Limited |
Novel formulations of angiotensin ii receptor antagonists
|
US10736905B1
(en)
|
2016-09-09 |
2020-08-11 |
Shahin Fatholahi |
Nefopam dosage forms and methods of treatment
|
US20180193283A1
(en)
|
2016-12-20 |
2018-07-12 |
Lts Lohmann Therapie-Systeme Ag |
Transdermal therapeutic system containing asenapine
|
CA3047354A1
(en)
|
2016-12-20 |
2018-06-28 |
Lts Lohmann Therapie-Systeme Ag |
Transdermal therapeutic system containing asenapine and polysiloxane or polyisobutylene
|
WO2018129304A1
(en)
|
2017-01-06 |
2018-07-12 |
Chrono Therapeutics Inc. |
Transdermal drug delivery devices and methods
|
WO2019002204A1
(en)
|
2017-06-26 |
2019-01-03 |
Lts Lohmann Therapie-Systeme Ag |
Transdermal therapeutic system containing asenapine and silicone acrylic hybrid polymer
|
US10736874B1
(en)
|
2017-09-08 |
2020-08-11 |
Shahin Fatholahi |
Methods for treating pain associated with sickle cell disease
|
US11446311B2
(en)
|
2017-09-08 |
2022-09-20 |
Shahin Fatholahi |
Methods for treating pain associated with sickle cell disease
|
EP3775086B1
(en)
|
2018-04-05 |
2022-09-14 |
3M Innovative Properties Company |
Gel adhesive comprising crosslinked blend of polydiorganosiloxane and acrylic polymer
|
EP3801732A4
(en)
|
2018-05-29 |
2022-04-27 |
Morningside Venture Investments Limited |
Drug delivery methods and systems
|
BR112020026099A2
(en)
|
2018-06-20 |
2021-03-23 |
Lts Lohmann Therapie-Systeme Ag |
transdermal therapeutic system containing asenapine
|
MX2021002833A
(en)
*
|
2018-09-27 |
2021-05-27 |
Biophysics Pharma Inc |
Transdermal drug delivery system.
|
US11633405B2
(en)
|
2020-02-07 |
2023-04-25 |
Therapeuticsmd, Inc. |
Steroid hormone pharmaceutical formulations
|
CA3232272A1
(en)
*
|
2021-10-15 |
2023-04-20 |
Hans-Werner Wolf |
Transdermal therapeutic system for the transdermal administration of tizanidine
|